← Eichor
Study identifier: NCT07328360 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Efficacy of High-Power Laser Therapy in Meralgia Paresthetica

Condition: Meralgia Paresthetica  ·  Sponsor: Uşak University

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The management of MP typically follows a conservative pathway, encompassing patient education, lifestyle modifications (e.g., avoidance of tight garments, weight loss), pharmacotherapy (such as neuropathic pain agents or corticosteroid injections), and physical therapy. However, evidence supporting the efficacy of these interventions is largely anecdotal or derived from low-quality studies, and a substantial proportion of patients experience persistent symptoms refractory to standard care. Therefore, the primary objective of this randomized, sham-controlled, assessor-blinded study is to investigate the efficacy of HPLT as an adjunct to standard conservative care on pain intensity, sensory symptoms, and functional capacity in patients with chronic Meralgia Paresthetica. The investigators hypothesize that patients receiving active HPLT will demonstrate significantly greater improvements in these outcomes compared to those receiving a sham laser procedure

This description comes directly from the study's public registry record.

Talk to the study team

Ali Y Karahan, Prof.  ·  +9053869219134  ·  ali.karahan@usak.edu.tr

Ender Salbas, Asst. Prof.  ·  +905556698639  ·  drendersalbas@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Usak UniversityUşak, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07328360